• About
  • Blog
  1. Home
  3. Blog
  5. Companies
  7. AURA

Aura Biosciences, Inc.(AURA)

NASDAQ Global Market
Sector: Healthcare | Industry: Biotechnology
Aura Biosciences, Inc. logo

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Latest News & Analysis

Aura Biosciences (AURA) stock analysis: Recent developments, market trends, and potential of Bel-sar in oncology.
Feb 20, 2025

Aura Biosciences, Inc. Announces Major Business Developments | Latest Industry News

Aura Biosciences navigates the oncology landscape with Bel-sar, focusing on clinical trials and market potential. Recent data and analyst estimates shape its trajectory.

Read more →

Professional-grade financial analysis tools for informed investment decisions.

Product

  • Features
  • Pricing

Resources

  • Blog
  • Knowledge Base
  • Community
  • Market Data

Company

  • About
  • Careers
  • Contact
  • Partners

Legal

  • Privacy
  • Terms
  • License
  • Security

© 2025 Monexa. All rights reserved. Market data provided by financial exchanges and may be delayed as specified by financial exchanges or our data providers.